E-LIB Suche - Ergebnisse für: Yurdaydın, C.

1

A virological response to PEG-IFNa treatment of hepatitis d..:

Wranke, A. ; Yurdaydin, C. ; Heidrich, B....
Journal of Hepatology. 68 (2018) - p. S507 , 2018

Link: https://doi.org/10.1016/..

2

Subanalysis of the LOWR HDV-2 study reveals high response r..:

Yurdaydin, C. ; Kalkan, C. ; Karakaya, F....
Journal of Hepatology. 68 (2018) - p. S89 , 2018

Link: https://doi.org/10.1016/..

3

Viral dominance patterns in chronic hepatitis delta determi..:

Lutterkort, G. L. ; Wranke, A. ; Hengst, J....
Journal of Viral Hepatitis. 25 (2018) 11 - p. 1384-1394 , 2018

Link: https://doi.org/10.1111/..

4

Health-related Quality of Life of Liver Donors: A Prospecti..:

Hesimov, I. ; Kirimker, E.O. ; Duman, B....
Transplantation Proceedings. 50 (2018) 10 - p. 3076-3081 , 2018

Link: https://doi.org/10.1016/..

5

Pharmacokinetics and pharmacodynamics modeling of ritonavir..:

Dubey, P. ; Koh, C. ; Surana, P....
Journal of Hepatology. 68 (2018) - p. S508 , 2018

Link: https://doi.org/10.1016/..

6

A phase 2 study exploring once daily dosing of ritonavir bo..:

Koh, C. ; Surana, P. ; Han, T....
Journal of Hepatology. 66 (2017) 1 - p. S101-S102 , 2017

Link: https://doi.org/10.1016/..

7

A phase 2 dose-optimization study of lonafarnib with ritona..:

Yurdaydin, C. ; Idilman, R. ; Keskin, O....
Journal of Hepatology. 66 (2017) 1 - p. S33-S34 , 2017

Link: https://doi.org/10.1016/..

8

In patients under treatment, chronic hepatitis D is a great..:

Keskin, O. ; Idilman, R. ; Kalkan, C....
Journal of Hepatology. 66 (2017) 1 - p. S687-S688 , 2017

Link: https://doi.org/10.1016/..

9

Viral Dominance patterns in hepatitis delta patients are as..:

Lutterkort, G.L. ; Anika, W. ; Hengst, J....
Journal of Hepatology. 66 (2017) 1 - p. S486 , 2017

Link: https://doi.org/10.1016/..

10

Diversity of clinical presentation and virological characte..:

Wranke, A. ; Hardtke, S. ; Borzacov, L.M.P....
Journal of Hepatology. 66 (2017) 1 - p. S257-S258 , 2017

Link: https://doi.org/10.1016/..

11

The prenylation inhibitor lonafarnib can induce post-treatm..:

Yurdaydin, C. ; Idilman, R. ; Kalkan, C....
Journal of Hepatology. 66 (2017) 1 - p. S259 , 2017

Link: https://doi.org/10.1016/..

12

Value of non-invasive fibrosis markers in chronic hepatitis..:

Kalkan, C. ; Karakaya, F. ; Keskin, O....
Journal of Hepatology. 66 (2017) 1 - p. S473 , 2017

Link: https://doi.org/10.1016/..

13

Hepatitis Delta Virus Kinetics under the Prenylation Inhibi..:

Yurdaydin, C. ; Borochov, N. ; Kalkan, C....
Journal of Hepatology. 64 (2016) 2 - p. S587 , 2016

Link: https://doi.org/10.1016/..

14

Non-Invasive Clinical Scores to Identify Liver Fibrosis in ..:

Lutterkort, G.L. ; Wranke, A. ; Yurdaydin, C....
Journal of Hepatology. 64 (2016) 2 - p. S361 , 2016

Link: https://doi.org/10.1016/..

15

Pharmacokinetics and Pharmacodynamics Modeling of Lonafarni..:

Canini, L. ; Koh, C. ; Cotler, S.J....
Journal of Hepatology. 64 (2016) 2 - p. S589 , 2016

Link: https://doi.org/10.1016/..